玻璃体淀粉样变性:眼部、全身及遗传学见解
回顾性观察研究纳入2个家系5例患者共10眼玻璃体淀粉样变性,总结临床与手术特征、玻璃体切除术后视力结局及全身评估意义;1例基因测序发现转甲状腺素蛋白基因(TTR)第2外显子第33位苯丙氨酸→异亮氨酸新突变,确诊家族性淀粉样多神经病(FAP)。
要点
- 9眼有晶状体假足,10眼均有玻璃棉样玻璃体混浊。
- 术中均见蜡纸样玻璃体及沿视网膜血管的牢固玻璃体粘连。
- 玻璃体切除术后最佳矫正视力(BCVA)由术前1.39±0.64 logMAR提高至0.17±0.07 logMAR(P=0.004)。
核心结论
- 研究强调玻璃体淀粉样变性的临床线索、处理策略、手术特征、玻璃体切除结局及全身评估意义。
- 报告了印度1例伴玻璃体淀粉样变性的FAP患者中的新单突变(Phe33Ile)。
研究设计与样本
- 回顾性观察研究,纳入2个家系5例患者共10眼,诊断为玻璃体淀粉样变性。
- 详细病史、家系图、全身及眼部检查,排除玻璃体炎、视网膜血管炎、玻璃体出血及全身淀粉样变性。
- 1例患者行基因分析;所有病例同一坐位行玻璃体活检及25G经平坦部玻璃体切除,标本行刚果红染色及偏振显微镜检查。
- 随访时间为第1、7、28天,之后每2个月;每次评估视力、眼压及眼底。
- 主要结局指标为TTR突变及术后视力。
主要发现
- 就诊平均年龄32岁,男女比例3:2,所有患者家族史阳性。
- 9眼有晶状体假足,10眼均有玻璃棉样玻璃体;1例患者(2眼)发生青光眼。
- 术中所有眼均见蜡纸样玻璃体及超出主要血管弓、沿视网膜血管的牢固玻璃体粘连。
- 刚果红染色及苹果绿双折射证实玻璃体淀粉样变性。
- 术前平均BCVA为1.39±0.64 logMAR,术后提高至0.17±0.07 logMAR(P=0.004)。
关键数值与推荐
- 玻璃体淀粉样变性诊断依据刚果红染色及苹果绿双折射。
- TTR第2外显子第33位苯丙氨酸→异亮氨酸突变(Phe33Ile)确诊FAP。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To report the unique clinical and surgical characteristics encountered in eyes with vitreous amyloidosis. Systemic evaluation and visual outcome after vitrectomy are discussed. A novel mutation in the transthyretin gene (TTR) in Indian patients with familial amyloid polyneuropathy (FAP) is described. DESIGN: Retrospective, observational study. PARTICIPANTS: Ten eyes of 5 patients from 2 pedigrees with a diagnosis of vitreous amyloidosis. METHODS: Detailed history, pedigree charting, systemic and ocular examination of 10 eyes (5 patients from 2 pedigrees) were carried out. Tests were performed to rule out vitreitis, retinal vasculitis, vitreous hemorrhage, and systemic amyloidosis. Genetic analysis to identify the mutation was performed in 1 patient. Vitreous biopsy, followed by 25-gauge pars plana vitrectomy, was performed in the same sitting in all cases. Samples were sent for Congo red staining and polarized microscopy. Patients were followed up on days 1, 7, and 28 and then every 2 months. Visual acuity assessment, intraocular pressure measurement, and fundus examination were performed each time. MAIN OUTCOME MEASURES: Mutations in TTR and postoperative visual acuity. RESULTS: Mean age at presentation was 32 years, with a 3:2 male-to-female distribution. Family history was positive in all patients. Nine eyes had pseudopodia lentis, whereas all 10 had glass wool-like vitreous. Glaucoma developed in 1 patient (2 eyes). Waxy paper-like vitreous with firm vitreous adhesions beyond major arcades and along retinal vessels was noted during surgery in all eyes. Congo red staining and apple green birefringence demonstrated vitreous amyloidosis. The mean preoperative best-corrected visual acuity (BCVA) was 1.39±0.64 logarithm of the minimum angle of resolution (logMAR), whereas the postoperative BCVA improved to 0.17±0.07 logMAR (P = 0.004). Gene sequencing revealed a phenylalanine→isoleucine mutation in the 33rd position of exon 2 of TTR in 1 patient of 1 pedigree, confirming the diagnosis of FAP. Two patients subsequently were found to have sensorimotor autonomic neuropathy, whereas 2 others had subclinical autonomic dysfunction. CONCLUSIONS: The clinical clues, management strategy, surgical characteristics, vitrectomy outcomes, and significance of systemic evaluation in vitreous amyloidosis are highlighted. A novel single mutation (Phe33Ile) in a case of FAP with vitreous amyloidosis from India is reported.
引用
- Venkatesh P, Selvan H, Singh SB, et al. Vitreous Amyloidosis: Ocular, Systemic, and Genetic Insights. Ophthalmology. 2017. PMID: 28412068. doi:10.1016/j.ophtha.2017.03.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。